Last edition
News about "Royalty Agreement"
Ferring Pharma and Royalty Pharma Enter into USD 500 Million Royalty Agreement for Adstiladrin
Royalty Pharma is acquiring a 5.1 percent royalty on net sales of Adstiladrin in the USA.
Royalty Agreement | 25/08/2023 | By Manvi | 224
Ferring Pharma and Royalty Pharma Enter into USD 500 Million Royalty Agreement for Adstiladrin
Royalty Pharma is acquiring a 5.1 percent royalty on net sales of Adstiladrin in the USA.
Royalty Agreement | 25/08/2023 | By Manvi | 224
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy